Please use this identifier to cite or link to this item:
|Title:||Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.|
|Authors:||Howell, Jessica;Angus, Peter W;Gow, Paul J;Visvanathan, Kumar|
|Affiliation:||Liver Transplant Unit, Austin Hospital, Victoria, Australia. Jess.Howell@austin.org.au|
|Citation:||Journal of Gastroenterology and Hepatology; 28(5): 766-76|
|Abstract:||Hepatitis C virus (HCV) infection is a significant global health problem, affecting over 150 million people worldwide. While the critical role of the adaptive immune system in HCV infection is well-established, the importance of the innate immune system in HCV infection has only been recognized in more recent years. Toll-like receptors form the cornerstone of the innate immune response, and there is considerable evidence for their crucial role in hepatitis C infection. This review outlines recent advances made in our understanding of the role of Toll-like receptor function in HCV infection, exploring how HCV manipulates host immunity to evade immune clearance and establish persistent infection despite leading to inflammatory hepatic damage.|
|Internal ID Number:||23432473|
Molecular Targeted Therapy
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.